Evidence map›Paper›PMID 38902610›Full record

ArticleBMC infectious diseases2024

Clinically inapparent mpox virus (MPXV) infections among clients of three anonymous Community Based Voluntary Counselling and Testing centres in Berlin, Germany, 2022-2023.

Uwe Koppe, Klaus Jansen, Axel Jeremias Schmidt, Christoph Weber, Heike Schulze, Robert Kasimir Kulis-Horn, Carsten Tiemann, Ulrich Marcus

Abstract read
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Uwe KoppeDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. koppeu@rki.de.ORCID http://orcid.org/0000-0001-9718-5811
Klaus JansenDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID http://orcid.org/0000-0002-4878-9421
Axel Jeremias SchmidtDeutsche Aidshilfe, Berlin, Germany.ORCID http://orcid.org/0000-0002-6910-4399
Christoph WeberCheckpoint BLN, Berlin, Germany.ORCID http://orcid.org/0009-0004-8743-852X
Heike SchulzeDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Robert Kasimir Kulis-HornMVZ Labor Krone, Bad Salzuflen, Germany.ORCID http://orcid.org/0000-0001-5803-8624
Carsten TiemannMVZ Labor Krone, Bad Salzuflen, Germany.ORCID http://orcid.org/0000-0003-0240-1468
Ulrich MarcusDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID http://orcid.org/0000-0002-3143-2717

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSince the mpox outbreak in 2022, it was unclear if and how often infections with mpox virus (MPXV) were clinically inapparent, i.e. not presenting to clinical care with mpox symptoms. Moreover, it was hypothesized that MPXV circulated in the affected communities before the outbreak was officially detected.

methodsWe retrospectively tested rectal and urethral swabs, and pooled samples for presence of MPXV. Samples were obtained from routine STI testing of three anonymous Community Based Voluntary Counselling and Testing (CBVCT) centres in Berlin, in 2022 and 2023. Testing results were linked to anonymously provided behavioural data.

resultsOverall, 9,053 samples from 6,600 client visits were included. Clinically inapparent MPXV infections were detectable in 1.1% of the samples. We did not find MPXV infections in the month before the first cases appeared in Berlin or between October 2022 and January 2023 when case numbers were low in Germany. However, during the outbreak period in 2022, we found clinically inapparent MPXV infections among 2.2% of the clients and during summer/autumn 2023 among 0.3%. The number of condomless anal/vaginal intercourse partners within the previous 6 months and PrEP use were identified as predictors of clinically inapparent MPXV infection.

conclusionClinically inapparent MPXV infections occurred during the mpox outbreak in Berlin in 2022 and post-outbreak in summer/autumn 2023. Unrecognized MPXV circulation in Berlin before the recognition of the outbreak in May 2022 appears unlikely. However, low-level sustained circulation of clinically inapparent MPXV infections need to be acknowledged in mpox prevention strategies.

Indexed as

CounselingMpox, MonkeypoxAdultBerlinDisease OutbreaksFemaleGermanyHumansMaleMiddle AgedRetrospective StudiesYoung AdultClinically inapparent infectionMpoxMPXV

Identifiers

PMID38902610
PMCPMC11191340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.